VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JSPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JSPRJasper Therapeutics, Inc.
$0.48$8M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJSPRQuarterly Financials

Jasper Therapeutics, Inc. (JSPR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Jasper Therapeutics, Inc. (JSPR) quarterly income statement — complete revenue, gross profit & net income history

JSPR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold21K0000000288K00000000000
COGS % of Revenue--------------------
Gross Profit-21K0000000-288K00000000000
Gross Margin %--------------------
Gross Profit Growth %----100%---------------
Operating Expenses10.93M15.84M19.17M27.08M21.8M25.29M19.89M15.99M14.78M17.73M19.36M17.83M13.95M13.75M12.71M11.96M12.78M12.08M10.08M8.42M
OpEx % of Revenue--------------------
Selling, General & Admin5.12M4.48M4.78M5.88M5.64M5.51M5.43M4.7M4.49M3.89M4.51M4.53M4.14M4.46M3.69M3.83M4.59M3.42M2.89M3.26M
SG&A % of Revenue--------------------
Research & Development5.81M11.36M14.39M21.2M16.16M19.77M14.46M11.3M10.3M13.84M14.85M13.3M9.8M9.28M9.02M8.13M8.19M8.66M7.19M5.16M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-10.95M-15.84M-19.17M-27.08M-21.8M-25.29M-19.89M-15.99M-15.07M-17.73M-19.36M-17.83M-13.95M-13.75M-12.71M-11.96M-12.78M-12.08M-10.08M-8.42M
Operating Margin %--------------------
Operating Income Growth %49.77%37.36%3.64%-69.3%-44.65%-42.65%-2.72%10.29%-8.07%-28.94%-52.36%-49.02%-9.15%-13.78%-26.08%-42.11%-104.32%-102.79%-67.76%-40.02%
EBITDA-10.93M-15.55M-18.94M-26.82M-21.52M-25.04M-19.35M-15.69M-14.78M-17.44M-19.09M-17.55M-13.67M-13.47M-12.44M-11.74M-12.56M-11.89M-9.95M-8.39M
EBITDA Margin %--------------------
EBITDA Growth %49.21%37.9%2.12%-70.88%-45.58%-43.56%-1.37%10.59%-8.13%-29.45%-53.42%-49.44%-8.84%-13.34%-25.06%-40%-101.57%-7.16%-
D&A (Non-Cash Add-back)21K290K229K258K279K245K541K299K288K283K276K275K274K273K268K218K216K194K132K29K
EBIT-10.95M-15.84M-18.74M-27.08M-21.8M-25.29M-19.89M-15.99M-15.07M-17.73M-19.36M-17.83M-13.95M-13.75M-12.71M-11.96M-12.78M-12.08M-3.4M-8.42M
Net Interest Income164K338K342K437K624K938K1.28M1.45M1.39M1.23M1.43M1.44M1.1M0259K92K2K0-9K0
Interest Income164K338K342K437K624K938K1.28M1.45M1.39M1.23M1.43M1.44M1.1M0259K92K2K000
Interest Expense0000000000000000009K0
Other Income/Expense9.78M6.74M430K353K561K964K1.25M1.41M1.34M1.14M1.82M1.75M-313K536K845K1.56M10.57M3.02M6.67M4K
Pretax Income-1.17M-9.1M-18.74M-26.72M-21.24M-24.32M-18.64M-14.58M-13.73M-16.58M-17.54M-16.08M-14.26M-13.21M-11.86M-10.4M-2.21M-9.06M-3.41M-8.41M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.17M-9.1M-18.74M-26.72M-21.24M-24.32M-18.64M-14.58M-13.73M-16.58M-17.54M-16.08M-14.26M-13.21M-11.86M-10.4M-2.21M-9.06M-3.41M-8.41M
Net Margin %--------------------
Net Income Growth %94.47%62.58%-0.53%-83.25%-54.73%-46.68%-6.23%9.31%3.73%-25.51%-47.89%-54.56%-546.13%-45.87%-247.68%-23.65%77.37%9.31%68.48%10.71%
Net Income (Continuing)-1.17M-9.1M-18.74M-26.72M-21.24M-24.32M-18.64M-14.58M-13.73M-16.58M-17.54M-16.08M-14.26M-13.21M-11.86M-10.4M-2.21M-9.06M-3.41M-8.41M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.08-0.59-1.13-1.74-1.41-1.62-1.24-0.97-1.03-1.50-1.60-1.47-1.62-3.60-3.24-2.86-0.61-11.07-6.87-39.97
EPS Growth %94.57%63.58%8.87%-79.38%-36.89%-8%22.5%34.01%36.42%58.33%50.62%48.6%-165.57%67.48%52.84%92.84%98.76%79.58%88.81%25.35%
EPS (Basic)-0.06-0.47-1.13-1.74-1.41-1.62-1.24-0.97-1.03-1.50-1.60-1.47-1.62-3.60-3.24-2.86-0.61-11.08-6.88-40.07
Diluted Shares Outstanding15.33M15.33M16.64M15.33M15.02M15.01M15M14.99M13.33M11.04M10.97M10.92M8.79M3.67M3.66M3.64M3.63M818K496.62K210.49K
Basic Shares Outstanding19.17M19.17M16.58M15.33M15.02M15.01M15M14.99M13.33M11.04M10.97M10.92M8.79M3.67M3.66M3.64M3.63M817.5K496K210K
Dividend Payout Ratio--------------------